Pharmaceutical Drugs Industry: Global Competitive Landscape 2021
Description
Pharmaceutical Drugs Industry: Global Competitive Landscape 2021
Report Scope:
This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies and company profiles are discussed in detail. The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape analysis that focuses on recent regulations in regions such as the U.S., Europe and Japan.
Report Includes:
71 data tables and 54 additional tables
A brief general overview of the global pharmaceutical drugs industry competitive landscape
Analyses of the global market trends, with historic market revenue for 2016 to 2021, estimates for 2022, market forecasts for 2022-2026, and projections of compound annual growth rates (CAGRs) through 2027
Assessment of major driving factors, opportunities and challenges in this innovation driven market, with emphasis on recent developments in the pharmaceutical industry
Highlights of the current and future market potential of pharmaceutical industry along with a detailed analysis of the competitive environment, regulatory scenario and clinical trails
Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on recent developments and region-specific macroeconomic factors on global pharmaceutical drugs marketplace
Market assessment of the COVID-19 impact on the global pharmaceutical drugs market, along with its implications on demand and supply, price impact and various government strategic decisions
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
Descriptive company profiles of the leading pharma manufacturers, including Abbott, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Pfizer Inc., Sanofi Corp., Takeda Pharmaceutical Co. Ltd. and Zydus Cadila
Companies Mentioned
A. Menarini Industrie Farmaceutiche Riunite S.R.L.
Abbott
Abbvie Inc.
Alexion Pharmaceuticals Inc.
Amgen Inc.
Asahi Kasei Corp.
Astellas Pharma Inc.
Astrazeneca
Aurobindo Pharma
Bausch Health Companies Inc.
Bayer Ag
Biogen
Boehringer Ingelheim International Gmbh
Bristol Myers Squibb Company
China National Pharmaceutical Group Corp. (Sinopharm)
Chugai Pharmaceutical Co. Ltd.
Csl Ltd.
Daiichi Sankyo Co. Ltd.
Dr. Reddy’s Laboratories Ltd.
Eisai Co. Ltd.
Eli Lilly And Co.
Endo International Plc
F. Hoffmann-la Roche Ltd. (Roche)
Gilead Sciences Inc.
Glaxosmithkline Plc
Grifols S.A.
H. Lundbeck A/S
Incyte
Ipsen Pharma
Johnson & Johnson Services Inc.
Mallinckrodt Plc
Merck & Co. Inc.
Merck Kgaa
Moderna Inc.
Novartis Ag
Novo Nordisk A/S
Otsuka Holdings Co. Ltd.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Sanofi
Servier Laboratories
Shanghai Pharmaceuticals Holding
Shionogi & Co. Ltd.
Stada Arzneimittel Ag
Sumitomo Pharma Co. Ltd.
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Co. Ltd.
Teva Pharmaceutical Industries Ltd.
Ucb S.A.
Vertex Pharmaceuticals Inc.
Viatris Inc.
Zydus Cadila
Report Scope:
This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies and company profiles are discussed in detail. The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape analysis that focuses on recent regulations in regions such as the U.S., Europe and Japan.
Report Includes:
71 data tables and 54 additional tables
A brief general overview of the global pharmaceutical drugs industry competitive landscape
Analyses of the global market trends, with historic market revenue for 2016 to 2021, estimates for 2022, market forecasts for 2022-2026, and projections of compound annual growth rates (CAGRs) through 2027
Assessment of major driving factors, opportunities and challenges in this innovation driven market, with emphasis on recent developments in the pharmaceutical industry
Highlights of the current and future market potential of pharmaceutical industry along with a detailed analysis of the competitive environment, regulatory scenario and clinical trails
Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on recent developments and region-specific macroeconomic factors on global pharmaceutical drugs marketplace
Market assessment of the COVID-19 impact on the global pharmaceutical drugs market, along with its implications on demand and supply, price impact and various government strategic decisions
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
Descriptive company profiles of the leading pharma manufacturers, including Abbott, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Pfizer Inc., Sanofi Corp., Takeda Pharmaceutical Co. Ltd. and Zydus Cadila
Companies Mentioned
A. Menarini Industrie Farmaceutiche Riunite S.R.L.
Abbott
Abbvie Inc.
Alexion Pharmaceuticals Inc.
Amgen Inc.
Asahi Kasei Corp.
Astellas Pharma Inc.
Astrazeneca
Aurobindo Pharma
Bausch Health Companies Inc.
Bayer Ag
Biogen
Boehringer Ingelheim International Gmbh
Bristol Myers Squibb Company
China National Pharmaceutical Group Corp. (Sinopharm)
Chugai Pharmaceutical Co. Ltd.
Csl Ltd.
Daiichi Sankyo Co. Ltd.
Dr. Reddy’s Laboratories Ltd.
Eisai Co. Ltd.
Eli Lilly And Co.
Endo International Plc
F. Hoffmann-la Roche Ltd. (Roche)
Gilead Sciences Inc.
Glaxosmithkline Plc
Grifols S.A.
H. Lundbeck A/S
Incyte
Ipsen Pharma
Johnson & Johnson Services Inc.
Mallinckrodt Plc
Merck & Co. Inc.
Merck Kgaa
Moderna Inc.
Novartis Ag
Novo Nordisk A/S
Otsuka Holdings Co. Ltd.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Sanofi
Servier Laboratories
Shanghai Pharmaceuticals Holding
Shionogi & Co. Ltd.
Stada Arzneimittel Ag
Sumitomo Pharma Co. Ltd.
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Co. Ltd.
Teva Pharmaceutical Industries Ltd.
Ucb S.A.
Vertex Pharmaceuticals Inc.
Viatris Inc.
Zydus Cadila
Table of Contents
307 Pages
- Chapter 1 Introduction
- 1.1 Study Goals And Objectives
- 1.2 Reasons For Doing This Study
- 1.3 Scope Of Report
- 1.4 Methodology
- 1.4.1 Primary Data And Information Gathering
- 1.4.2 Secondary Data And Information Gathering
- 1.5 Market Revenue Forecasts
- 1.6 Analyst's Credentials
- 1.7 Bcc Custom Research
- 1.8 Related Bcc Research Reports
- Chapter 2 Market And Technology Background
- 2.1 Background And Definitions: Pharmaceutical Drugs
- 2.2 Uses Of Various Drugs
- 2.3 Background: Innovation In The Pharmaceutical Industry
- 2.4 Stakeholders Involved In The Innovation Process
- 2.5 The Pharmaceutical Industry
- 2.6 The Cost Of Pharmaceutical Drug Innovation
- 2.7 Current Trends In The Pharmaceuticals Industry
- 2.7.1 Digital Transformation And Technological Developments
- 2.7.2 Increasing R&D Spend And Shift Toward Modern Therapeutics And Technologies
- 2.7.3 Collaborations For Advanced Therapeutics
- 2.7.4 Market Consolidation For Strategic Growth And To Retain Market Leadership
- 2.8 Notable Trends
- 2.8.1 Income Growth In Developing Markets
- 2.8.2 Changing Structure Of The Pharma And Healthcare Industry
- 2.8.3 Lifestyle Medicine
- 2.8.4 Patient-centric Programs
- 2.8.5 Prevalence Of Self-care
- 2.8.6 Burden On Public Health System
- 2.9 Importance Of Innovation
- 2.10 Challenges Facing The Sector
- 2.10.1 Public Health Systems
- 2.10.2 Balancing Patient Needs And Financial Sustainability
- 2.10.3 Competitiveness And Innovation
- 2.11 Market Dynamics
- 2.11.1 Drivers
- 2.11.2 Restraints
- 2.12 Opportunities
- 2.13 Strategies
- 2.14 Distribution Network
- 2.14.1 Asia-pacific
- 2.14.2 U.S.
- 2.14.3 Europe
- 2.14.4 India
- 2.14.5 China
- 2.14.6 Japan
- 2.14.7 South Korea
- 2.15 Recommendations
- Chapter 3 Impact Of Covid-19 On The Pharmaceutical Drug Market
- 3.1 Overview
- 3.2 Covid-19 Crisis
- 3.3 Impact On Market
- 3.4 Current Outlook
- 3.4.1 Implications On Cancer Diagnosis
- 3.4.2 Implications On Cancer Treatment
- 3.4.3 Impact On Oncology Pharmaceuticals Market
- 3.5 Implications On Cancer Treatment
- 3.5.1 Key Impacts Of Covid-19
- Chapter 4 Regulatory Structure: Pharmaceutical Drug Market
- 4.1 Regulatory Background
- 4.2 Regulatory Systems For Biopharmaceuticals By Region
- 4.2.1 U.S.
- 4.2.2 Europe
- 4.2.3 Japan
- 4.3 Regulatory Systems For Pharmaceuticals By Region
- 4.3.1 U.S.
- 4.3.2 Japan
- 4.3.3 India
- 4.3.4 Brazil
- 4.4 Regulations For Vaccines
- 4.4.1 Current Regulatory Issues For Vaccines
- 4.4.2 Moderna Vaccine Regulation In The U.K.
- 4.5 Key Regulatory Updates, 2020
- 4.5.1 Pharmaceuticals
- 4.5.2 Medical Devices
- 4.6 Code Of Federal Regulations (Cfr)
- 4.7 Good Manufacturing Compliance (Gmp) Compliance
- 4.8 Establishment Registration
- 4.9 Drug Registration And Listing
- 4.10 Local Agent Requirements
- 4.10.1 Responsibilities Of The U.S. Agent
- Chapter 5 Pricing And Reimbursement: Pharmaceuticals And Biologics
- 5.1 Pricing And Reimbursement Background
- 5.2 Pricing And Reimbursement Of Pharmaceuticals And Biologics By Region
- 5.2.1 U.S.
- 5.2.2 Europe
- 5.2.3 Japan
- 5.3 Pricing And Reimbursement Challenges For Pharmaceuticals
- 5.3.1 Patented Medicines Price
- 5.3.2 Prices Of Older Drugs
- 5.4 Pricing And Reimbursement For Medical Devices By Region
- 5.4.1 U.S.
- 5.4.2 Europe
- 5.4.3 Japan
- 5.5 Other Parts Of Asia-pacific
- Chapter 6 Pharmaceutical Drugs Industry: Competitive Landscape
- 6.1 Overview
- 6.2 Key Strategies Of Major Pharmaceutical Drugs Manufacturers
- 6.2.1 Distribution Network
- 6.2.2 Trends
- 6.2.3 Mergers And Acquisitions
- 6.2.4 Recommendations
- 6.3 Key Developments Of The Major Pharmaceutical Drugs Manufacturers
- 6.3.1 Mergers And Acquisitions In Pharmaceutical Drugs Market
- 6.3.2 Agreements, Joint Ventures, Expansions, Divestments And Investments, Pharmaceuticals Market
- 6.3.4 New Product Launches And Approvals
- 6.4 Long-term Outlook
- Chapter 7 Company Profiles
- Abbott
- Abbvie Inc.
- Alexion Pharmaceuticals Inc.
- Amgen Inc.
- Astellas Pharma Inc.
- Astrazeneca
- Asahi Kasei Corp.
- Aurobindo Pharma
- Bausch Health Companies Inc.
- Bayer Ag
- Biogen
- Boehringer Ingelheim International Gmbh
- Bristol Myers Squibb Company
- Chugai Pharmaceutical Co. Ltd.
- Csl Ltd.
- Daiichi Sankyo Co. Ltd.
- Dr. Reddy’s Laboratories Ltd.
- Eisai Co. Ltd.
- Eli Lilly And Co.
- Endo International Plc
- Gilead Sciences Inc.
- Glaxosmithkline Plc
- Grifols S.A.
- H. Lundbeck A/S
- Incyte
- Ipsen Pharma
- Johnson & Johnson Services Inc.
- Mallinckrodt Plc
- A. Menarini Industrie Farmaceutiche Riunite S.R.L.
- Merck & Co. Inc.
- Merck Kgaa
- Moderna Inc.
- Novartis Ag
- Novo Nordisk A/S
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- F. Hoffmann-la Roche Ltd. (Roche)
- Sanofi
- Servier Laboratories
- Shanghai Pharmaceuticals Holding
- Shionogi & Co. Ltd.
- China National Pharmaceutical Group Corp. (Sinopharm)
- Stada Arzneimittel Ag
- Sumitomo Pharma Co. Ltd.
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Ucb S.A.
- Vertex Pharmaceuticals Inc.
- Viatris Inc.
- Zydus Cadila
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
